Director at the Mayo Clinic and Mayo Clinic Laboratories In Rochester, Minnesota; Associate Professor of Medicine and Laboratory Medicine, Mayo Clinic College of Medicine and Science
BIOGRAPHY
JUN 07, 2022 10:00 AM PDT
New 2021 CDC HIV PrEP (Preexposure Prophylaxis) Guidelines: Implications for Clinicians and Laboratories
Speaker
Event Date & Time
Date: June 07, 2022
Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST)
Abstract
On December 8th, 2021 the CDC released new recommendations for preexposure prophylaxis (PrEP) for the prevention of HIV infection in the US. These new guidelines include important updates designed to help increase access to and awareness of PrEP as well as new recommendations for laboratory testing. This webinar will review these important changes and discuss how they will impact patients, clinicians, and the clinical laboratories providing results that play a critical role in this updated approach.
Learning Objectives
- Outline current HIV/PrEP landscape in the US
- Describe important changes in the new 2021 CDC PrEP Guidelines
- Review rationale of new recommendations for NAAT in PrEP monitoring and potential impact on clinical laboratories, clinicians, and patients
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
NOV 04, 2025 | 8:00 AM
Even in the most controlled labs, balance performance can drift — electrostatics, air drafts, temperature shifts, or even the way samples are handled can quietly undermine your results...
NOV 04, 2025 | 8:00 AM
Unlock the full potential of your LC-MS system with Thermo Scientific™ Chromeleon™ software features. This webinar will demonstrate the system suitability test with intelligent r...
NOV 05, 2025 | 10:00 AM
Research in plant and animal genomics often involve complex genetic challenges that require tailored approaches. From addressing genetic complexity in aquaculture species to investigating tr...
NOV 05, 2025 | 8:00 AM
Do you use pipettes in your daily work? Want to improve your pipetting accuracy? To eliminate the guesswork, METTLER TOLEDO Rainin developed Good Pipetting Practice™ (GPP™) as a...
NOV 05, 2025 | 9:00 AM
BACKGROUND . Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid neoplasms with variable clinical outcomes and an increased risk of progression to Acute Myeloid Leukemia (AM...
NOV 06, 2025 | 10:00 AM
C.E. CREDITS
Discover how MSK-IMPACT® Flex with SOPHiA DDM™ enables modular, cost-efficient genomic profiling with flexible DNA/RNA biomarker analysis....
Loading Comments...